Get the Stockscreener App
25.17
0.40%
-0.10
After Hours:
25.17
Quidelortho Corporation stock is traded at $25.17, with a volume of 938.60K.
It is down -0.40% in the last 24 hours and down -30.47% over the past month.
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.
See More
Previous Close:
$25.27
Open:
$24.83
24h Volume:
938.60K
Relative Volume:
0.94
Market Cap:
$1.84B
Revenue:
$2.82B
Net Income/Loss:
$-1.87B
P/E Ratio:
-0.9022
EPS:
-27.9
Net Cash Flow:
$-96.80M
1W Performance:
-4.73%
1M Performance:
-30.47%
6M Performance:
-37.18%
1Y Performance:
-34.98%
1-Day Range:
$24.44
$25.45
1-Week Range:
$24.44
$27.73
52-Week Range:
$24.44
$49.45
Quidelortho Corporation Stock (QDEL) Company Profile
Name
Quidelortho Corporation
Sector
Industry
Phone
(858) 552-1100
Address
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corporation
|
25.17 | 1.84B | 2.82B | -1.87B | -96.80M | -27.90 |
|
ABT
Abbott Laboratories
|
130.98 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.12 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
346.50 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
82.60 | 108.02B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.53 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-11-24 | Upgrade | Citigroup | Neutral → Buy |
| Dec-10-24 | Initiated | Jefferies | Hold |
| Sep-19-24 | Resumed | UBS | Neutral |
| Sep-05-24 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-04-24 | Downgrade | UBS | Neutral → Sell |
| Feb-14-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-11-23 | Downgrade | Citigroup | Buy → Neutral |
| Dec-12-22 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-14-22 | Upgrade | UBS | Sell → Neutral |
| Sep-19-22 | Initiated | Citigroup | Neutral |
| Jul-20-22 | Initiated | UBS | Sell |
| Jun-17-22 | Resumed | JP Morgan | Neutral |
| Feb-22-22 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-22-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-12-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Mar-26-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Mar-08-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-22-18 | Reiterated | Barclays | Overweight |
| Jan-04-18 | Upgrade | CL King | Neutral → Buy |
| Sep-19-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jul-18-17 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jul-18-17 | Upgrade | William Blair | Mkt Perform → Outperform |
| Apr-25-17 | Reiterated | Canaccord Genuity | Hold |
| Feb-17-17 | Initiated | CL King | Neutral |
| Dec-16-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jun-13-16 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Feb-18-16 | Reiterated | Barclays | Overweight |
| Feb-09-16 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jan-08-16 | Reiterated | Canaccord Genuity | Buy |
| Dec-14-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-02-15 | Initiated | Barclays | Overweight |
| Jul-31-13 | Reiterated | Canaccord Genuity | Buy |
| Mar-03-11 | Downgrade | Wedbush | Outperform → Neutral |
View All
Quidelortho Corporation Stock (QDEL) Latest News
Drug Screening Market Size Worth USD 10.34 Billion by 2034 | CAGR of 4.84% from 2025 to 2034 - GlobeNewswire Inc.
Quidel stock hits 52-week low at $25 amid market challenges By Investing.com - Investing.com South Africa
Quidel stock hits 52-week low at $25 amid market challenges - Investing.com Canada
Press Release Distribution & PR Platform - ACCESS Newswire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against QuidelOrtho Corporation and Encourages Investors with Losses to Contact the Firm - marketscreener.com
QuidelOrtho (QDEL) Surges 10.1%: Is This an Indication of Further Gains? - MSN
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now - MSN
QuidelOrtho Corporation f/k/a Quidel Corporation Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your RightsQDEL - ACCESS Newswire
QuidelOrtho Corporation f/k/a Quidel Corporation Class Action: Levi & Korsinsky Reminds QuidelOrtho Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 11, 2024QDEL - ACCESS Newswire
Quidel stock hits 52-week low at $29.67 amid market challenges - Investing.com Australia
Medical Devices & SuppliesImaging, Diagnostics Stocks Q4 In Review: QuidelOrtho (NASDAQ:QDEL) Vs Peers - MSN
QuidelOrtho Corporation's (NASDAQ:QDEL) Business And Shares Still Trailing The Industry - simplywall.st
QuidelOrtho Corporation: What Is Their Latest Strategic Shift In Revenue Focus? - Smartkarma
Victory Capital Management Inc. Buys 8,493 Shares of QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho Unveils Results Manager System to Streamline Testing - MSN
QuidelOrtho launches Results Manager system for hospitals - MSN
Bank of New York Mellon Corp Cuts Stock Position in QuidelOrtho Co. (NASDAQ:QDEL) - Defense World
QuidelOrtho® Introduces Results Manager™ System - Quantisnow
QuidelOrtho launches new lab informatics system - Investing.com India
QuidelOrtho launches new lab informatics system By Investing.com - Investing.com South Africa
QuidelOrtho Co. (NASDAQ:QDEL) Shares Bought by Mutual of America Capital Management LLC - Defense World
QuidelOrtho Corp Reports Q4 Revenue of $708M, Exceeding Estimates; EPS Misses with $2.28 Loss - GuruFocus.com
Proficio Capital Partners LLC Acquires New Stake in QuidelOrtho Co. (NASDAQ:QDEL) - Defense World
QuidelOrtho shares surge 49% following July 2024 undervalued signal By Investing.com - Investing.com Canada
QuidelOrtho shares surge 49% following July 2024 undervalued signal - Investing.com India
Quidel Ortho at Raymond James Conference: Strategic Growth and Efficiency - Investing.com
Is QuidelOrtho Corporation (QDEL) the Best Medical Technology Stock to Buy According to Analysts? - Insider Monkey
QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Corporation Investors Can Join the Class Action Lawsuit! - ACCESS Newswire
QDEL SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds QuidelOrtho Corporation Investors to Join the Class Action Lawsuit - ACCESS Newswire
Shareholders that lost money on QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
QuidelOrtho Full Year 2024 Earnings: EPS Misses Expectations - Simply Wall St
9,598 Shares in QuidelOrtho Co. (NASDAQ:QDEL) Acquired by Sanctuary Advisors LLC - Defense World
Investors who lost money on QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) should contact Levi & Korsinsky about pending Class ActionQDEL - ACCESS Newswire
QDEL LAWSUIT ALERT: Levi & Korsinsky Notifies QuidelOrtho Corporation f/k/a Quidel Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire
Phocas Financial Corp. Sells 66,923 Shares of QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
Rhumbline Advisers Purchases 12,026 Shares of QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho CEO Terminated: Johnson Fistel Continues Investigation of QuidelOrtho on Behalf of Shareholders - ACCESS Newswire
Skylands Capital LLC Has $3.74 Million Stock Holdings in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
Levi & Korsinsky Notifies QuidelOrtho Corporation f/k/a Quidel Corporation Investors of a Class Action Lawsuit and Upcoming DeadlineQDEL - ACCESS Newswire
Levi & Korsinsky Reminds QuidelOrtho Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 11, 2024QDEL - ACCESS Newswire
QuidelOrtho Corp SEC 10-K Report - TradingView
QuidelOrtho Co. (NASDAQ:QDEL) Shares Sold by Leeward Investments LLC MA - MarketBeat
QuidelOrtho Co. (NASDAQ:QDEL) Shares Purchased by Rhumbline Advisers - Defense World
Ieq Capital LLC Grows Position in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
Shareholders of QuidelOrtho Corporation f/k/a Quidel Corporation Should Contact Levi & Korsinsky Before June 11, 2024 to Discuss Your RightsQDEL - ACCESS Newswire
Blue Trust Inc. Has $58,000 Stock Holdings in QuidelOrtho Co. (NASDAQ:QDEL) - Defense World
Quidelortho Corporation Stock (QDEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Quidelortho Corporation Stock (QDEL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Blaser Brian J. | President and CEO |
Dec 11 '24 |
Buy |
41.42 |
6,033 |
249,878 |
6,033 |
1.01%
0.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):